Short bioactive peptides
AssigneeHelix Biomedix, Inc.
InventorDonald R. Owen
Life of this patent
Estimating the term…
Abstract
Short bioactive peptides containing phenylalanine, leucine, alanine, and lysine residues are disclosed. The peptides can be used in antibacterial, antifungal, anticancer, and other biological applications.
Claims52
An isolated peptide comprising phenylalanine, leucine, alanine, and lysine residues, wherein:
- the peptide is about 5 to about 23 amino acids in length;
- and
- the peptide is at least about 50% phenylalanine, leucine, alanine, and lysine residues.
A method for inhibiting the growth of cancer cells, the method comprising contacting the cancer cells with a peptide;
- wherein:
- the peptide comprises phenylalanine, leucine, alanine, and lysine residues;
- the peptide is about 5 to about 23 amino acids in length;
- and
- the peptide comprises at least about 50% phenylalanine, leucine, alanine, and lysine residues.
A method of treating an animal, the method comprising administering to the animal a peptide, wherein:
- the animal contains cancer cells;
- the peptide comprises phenylalanine, leucine, alanine, and lysine residues;
- the peptide is about 5 to about 23 amino acids in length;
- and
- the peptide comprises at least about 50% phenylalanine, leucine, alanine, and lysine residues.
A method for inhibiting the growth of microbial cells, the method comprising contacting the microbial cells with a peptide;
- wherein:
- the peptide comprises phenylalanine, leucine, alanine, and lysine residues;
- the peptide is about 5 to about 23 amino acids in length;
- and
- the peptide comprises at least about 50% phenylalanine, leucine, alanine, and lysine residues.
Dependencies are inferred from the claim text.